Bristol-Myers Squibb to Take Part in Leerink Swann Global Health Care Conference

Wed Feb 6, 2013 2:02pm EST

* Reuters is not responsible for the content in this press release.

http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130206:nBw066404a

NEW YORK--(Business Wire)--
Bristol-Myers Squibb Company (NYSE: BMY) will take part in the Leerink Swann
2013 Global Health Care Conference on Wednesday, February 13, 2013, in New York.
Charles Bancroft, executive vice president and chief financial officer, will
answer questions about the company at 3:30 p.m. EST. 

Investors and the general public are invited to listen to a live webcast of the
session at http://investor.bms.com. An archived edition of the session will be
available later that day. 

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to
discover, develop and deliver innovative medicines that help patients prevail
over serious diseases. For more information, please visit www.bms.com or follow
us on Twitter at http://twitter.com/bmsnews.

Bristol-Myers Squibb Company
Media:
Jennifer Fron Mauer, 609-252-6579
jennifer.mauer@bms.com
or
Investors:
John Elicker, 609-252-4611
john.elicker@bms.com



Copyright Business Wire 2013

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.